Alicia Evangelista

Alicia Evangelista is the Genesis Labs Program Lead at the Novartis Institutes for Biomedical Research (NIBR). She has a background as a scientist and has transitioned into roles focused on innovation and connecting various stakeholders in the biomedical field. Alicia holds a PhD in molecular medicine from Boston University School of Medicine.

In her current position, she manages Genesis Labs, which is designed to foster multidisciplinary teams that validate disruptive concepts in drug discovery and development. Her career includes experience as a tech transfer associate at the National Institutes of Health (NIH), an innovation consultant for Fortune 500 companies and NASA, and serving as the Head of Innovation at the Swiss science and technology consulate in Boston (Swissnex) .123